Skip to content
Open access

Gut microbiota composition and dysbiosis signatures associated with complex gastrointestinal and urological conditions in neonates: a case series study

Oct 2026 · Frontiers in Medicine · 0 citations · 42 references

TL;DR

The findings suggest that early-life factors, including antibiotic exposure, prematurity, complex clinical conditions, and surgical interventions, may substantially affect microbial colonization, and alterations may be associated with an increased risk of complications and systemic inflammation.

Abstract

During the first year of life, the gut microbiota (GM) is influenced by several factors, including delivery mode, feeding practices (breast milk vs. formula milk), antibiotic therapy, and preterm birth. Surgical interventions and complex congenital conditions may further alter microbial colonization, potentially contributing to complications and systemic inflammation. This study aimed to investigate alterations in the GM of newborns with complex surgical, urological, and gastrointestinal conditions, including Hirschsprung's disease. GM composition was analyzed in five newborns with complex clinical conditions to investigate potential associations between microbial alterations and underlying diseases. A consistent reduction in beneficial commensal bacteria, particularly Bifidobacterium and Lactobacillus spp., was observed, alongside an increased abundance of potential opportunistic pathogens, mainly belonging to the phylum Proteobacteria. These findings revealed common signatures of dysbiosis, as well as potential disease-specific microbial patterns. The findings suggest that early-life factors, including antibiotic exposure, prematurity, complex clinical conditions, and surgical interventions, may substantially affect microbial colonization. These alterations may be associated with an increased risk of complications and systemic inflammation. Further studies involving larger cohorts are needed to clarify the relationships between GM alterations and clinical outcomes in these vulnerable newborns.

Read PDF

Similar papers

Review Open access Oct 2026

Probiotic modulation of gut microbiota in preterm infants: a narrative review of clinical evidence, mechanisms, and translational gaps

It is concluded that multi-strain probiotics reduce severe NEC and all-cause mortality, but evidence for LOS is inconsistent and neurodevelopmental benefit remains unproven, and routine universal use is not justified.

Dong-Ke Xie, Hao-Kun Yuan, De-Shuang Zhang · 0 citations
Review Open access Oct 2026

Intestinal microbiota, low-grade inflammation and probiotic modulation in symptomatic uncomplicated diverticular disease: experimental and clinical perspectives. A narrative review

Symptomatic Uncomplicated Diverticular Disease (SUDD) of the colon represents one of the most common gastrointestinal disorders in Western countries, with prevalence increasing significantly with age. Among its clinical manifestations, SUDD is characterized by recurrent abdominal pain, bloating, and alterations in bowe...

Giovanni Tomasello, Francesco Alamia, Riccardo Chiodo et al. · 0 citations
Review Open access Oct 2026

Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions

Gut microbiota dysbiosis has emerged as a key feature in pediatric acute lymphoblastic leukemia (ALL), driven by chemotherapy, antibiotic exposure, and treatment-related nutritional impairment. Increasing evidence indicates that disruption of microbial diversity and depletion of short-chain fatty acid–producing bacteri...

Ke Chen, Qing-Qing Li, Y. Xing et al. · 0 citations
Review Open access Oct 2026

Microbiome signatures and mechanistic pathways in pediatric obesity: from early-life risk to precision interventions.

Interventional studies indicate that dietary fiber enrichment and selected probiotic strains can improve microbial and metabolic outcomes in some settings, but efficacy remains strain-specific and clinically heterogeneous.

Shan-Shan Xie, Jie Hu, Wei Zhou et al. · 0 citations
Review Open access Oct 2026

Fecal microbiota transplant in the treatment of inflammatory bowel diseases: new perspectives on delivery, mechanism, and clinical positioning.

The evolving role of FMT within the therapeutic framework of chronic inflammation, focusing specifically on IBD, is examined and the variable clinical outcomes in IBD are compared with the highly successful model of recurrent CDI, highlighting mechanistic and clinical determinants of response in a different disease con...

Anum Javed, Despoina Chrysostomou, J. Marchesi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.